(Total Views: 626)
Posted On: 08/28/2025 8:31:48 PM
Post# of 156681
Re: biloxiblues #156475
Seems reasonable to make all these projections if Merck indeed buys us out, however, Merck will need to buy us out very soon after they have seen the data that supports their projections because why couldn't we simply get Leronlimab approved, raised all the capital we need, go it alone and combine it with any of the checkpoint inhibitors or even the generic version of Keytruda. They will need to own Leronlimab if they want to make a lot of money with the combo or they will not be making much on their subcutaneous version (IMHO of course 
)
I believe we will continue to move forward assuming both paths are in play. That is the smart thing to do. Anyone who says there is no NDA in play because we're raising awareness and cash is just a day trader trying to make a living, and I'm pretty sure there are a lot of them that comment on this board.
I personally would like to go it alone. I hope once we have data, we'll be able to do the same thing Gilead did. Might be wishful thinking, but with everything going on, it is not a crazy projection.
However, at $171/share, yeh, I'm approving that sale
) I believe we will continue to move forward assuming both paths are in play. That is the smart thing to do. Anyone who says there is no NDA in play because we're raising awareness and cash is just a day trader trying to make a living, and I'm pretty sure there are a lot of them that comment on this board.
I personally would like to go it alone. I hope once we have data, we'll be able to do the same thing Gilead did. Might be wishful thinking, but with everything going on, it is not a crazy projection.
However, at $171/share, yeh, I'm approving that sale
(10)
(0)
